Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

[1]  K. Ness,et al.  Adverse late effects of childhood cancer and its treatment on health and performance. , 2007, Annual review of public health.

[2]  L. Constine,et al.  Long-term effects of treatments for childhood cancers , 2007, Current opinion in pediatrics.

[3]  M. Loh,et al.  Factors Influencing Survival after Relapse from Childhood ALL: A Children’s Oncology Group Study. , 2006 .

[4]  M. Devidas,et al.  Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Devidas,et al.  Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. , 2005, Blood.

[6]  J. Cornish,et al.  Factors affecting the outcome of stem cell transplantation from unrelated donors for childhood acute lymphoblastic leukemia in third remission , 2005, Bone Marrow Transplantation.

[7]  J. Wagner,et al.  Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  P. Duffner.  Long-Term Effects of Radiation Therapy on Cognitive and Endocrine Function in Children With Leukemia and Brain Tumors , 2004, The neurologist.

[9]  N. Heerema,et al.  Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 2003, Blood.

[10]  N. Heerema,et al.  Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Richards,et al.  Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia , 2003, British Journal of Haematology.

[12]  B. Storer,et al.  Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. , 2002, Blood.

[13]  N. Heerema,et al.  Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 2002, Blood.

[14]  J. Wagner,et al.  Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. , 2001, Blood.

[15]  A. Nademanee,et al.  Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. , 2000, Blood.

[16]  B. Pollock,et al.  Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study . , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Wan Ariffin Bin Abdullah,et al.  Med Pediatr Oncol , 1999 .

[18]  G. Leverger,et al.  Total body irradiation–high‐dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA‐identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study , 1998, British journal of haematology.

[19]  P. Steinherz,et al.  Survival after relapse in childhood acute lymphoblastic leukemia , 1998, Cancer.

[20]  G. Henze,et al.  Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative? , 1997, Bone Marrow Transplantation.

[21]  D. Lin,et al.  Non-parametric inference for cumulative incidence functions in competing risks studies. , 1997, Statistics in medicine.

[22]  J. Wagner,et al.  Unrelated donor bone marrow transplantation for children with acute leukemia. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Wagner,et al.  Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. , 1996, Blood.

[24]  W. Woods,et al.  Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. , 1990, International journal of radiation oncology, biology, physics.

[25]  A I Goldman,et al.  Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. , 1987, The New England journal of medicine.

[26]  D. Arthur,et al.  Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  W. Woods,et al.  Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia. , 1983, Blood.

[28]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[29]  C. Pui.  Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. , 2006, Hematology. American Society of Hematology. Education Program.

[30]  R. Butler,et al.  Neurocognitive effects of treatment for childhood cancer. , 2006, Mental retardation and developmental disabilities research reviews.

[31]  T. Imamura,et al.  Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature , 2006, Bone Marrow Transplantation.

[32]  G. Henze,et al.  Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. , 1993, Medical and pediatric oncology.

[33]  D. Cox.  Regression Models and Life-Tables , 1972 .